is compounded tirzepatide being discontinued Compound Tirzepatide

In comparison, semaglutide showed an average weight reduction of 13.7% of initial body weight after 72 weeks

The SURMOUNT-1 three-year data showing that tirzepatide at 15 mg reduced new-onset type 2 diabetes to 0.4% versus 13.3% with placebo represents one of the most powerful preventive medicine findings in recent years

There are better solutions

But if you understand how this whole system works, you can actually save yourself thousands of dollars annually

It is currently approved only for type 2 diabetes mellitus (Mounjaro) and chronic weight management (Zepbound), and any potential addiction-related benefits remain investigational

Learning proper injection techniques also reduces local discomfort and makes the weekly routine smoother